Maximising both sensitivity and specificity for prediction of any cancer, a cut-point of 1.9 mg /l−1 was identified for levels of CRP (sensitivity and specificity both 57%) and of 62.0 μg l−1 for levels of YKL-40 (sensitivity and specificity both 59%). Here, CHI3L1 is linked to cancer.